Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Yenan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-0918-4534; OpenAlex author ID A5101987684. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma. Co-author DOI 10.1136/gutjnl-2023-330155↗
  2. Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer. Co-author DOI 10.3390/cancers13184569↗
  3. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis. First author DOI 10.1002/1878-0261.12684↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nathalia A. Giese · 3 shared papers, 2020–2023 · strength 0.40
  2. Thilo Hackert · 3 shared papers, 2020–2023 · strength 0.40
  3. Andrea S. Bauer · 3 shared papers, 2020–2023 · strength 0.40
  4. Jörg D. Hoheisel · 3 shared papers, 2020–2023 · strength 0.40
  5. Markus Wolfgang Büchler · 2 shared papers, 2021–2023 · strength 0.29
  6. Mehdi Manoochehri · 2 shared papers, 2020–2023 · strength 0.27
  7. Fawaz N. Al-Shaheri · 1 shared paper, 2023 · strength 0.16
  8. Oliver Strobel · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.